Immunization

Navigating the intricacies of specific formulations is of foremost importance to the community pharmacist.

The short shelf life of the live attenuated influenza vaccine may contribute to patients unwittingly receiving an expired dose.

The FDA has approved the use of Sanofi's Menactra vaccine as a booster immunization against meningococcal disease in patients at continued risk.

Parental and provider assumptions about sexual activity onset contribute to low HPV vaccination rates, the results of a study suggest.

Experimental vaccine could begin clinical trials in humans in early 2015.

Vaccine targets the diarrhea-causing bacterium linked to 14,000 US deaths annually.

Vast majority of parents are opting for their young children to receive potentially lifesaving vaccines despite the controversy surrounding their right to refuse such immunizations.

The FDA has approved the first needle-free device for injecting the Afluria influenza vaccine in adult patients aged 18 to 64 years.

Key points from the Infectious Diseases Society of America's updated guidelines for vaccination of immunocompromised individuals.

In a large-scale trial, Sanofi's Fluzone High-Dose vaccine demonstrated efficacy in preventing influenza specifically in adults aged 65 years or older.

Roughly one-third of teen girls' clinicians and almost half of teen boys' clinicians did not recommend HPV vaccination in 2013.

Several treatments for hemorrhagic fever are in different stages of development.

Learn what the latest guidelines from the American Academy of Pediatrics recommend for meningococcal vaccination among children, adolescents, and young adults.

Financial hurdles delay biopharmaceutical companies from developing treatment amidst largest Ebola hemorrhagic fever outbreak in history.

HPV vaccination rates remained low for the second consecutive year, the CDC reports.

The number of measles cases reported to the Centers for Disease Control and Prevention during the first 5 months of 2014 is the highest reported for that period since 1994.

A small study suggests that pertussis vaccination during pregnancy increases antibody concentration in infants without increasing the rate of adverse reactions.

A report finds that childhood vaccinations, boosted by the Vaccines for Children program, will prevent 322 million illnesses and 21 million hospitalizations throughout the lives of children born in the last 2 decades.

Research from the United Kingdom suggests that getting the influenza vaccine, especially early in the flu season, significantly reduces one's risk of stroke.

Getting childhood vaccinations according to the recommended schedule appears to reduce the risk of hospitalization for infections, according to the results of a Danish study.

Recommendations for vaccinations vary by age and risk.

A Danish study finds that vaccination against the human papillomavirus is associated with reduced rates of precancerous cervical lesions in young women.

Data from California indicate that there have been more severe flu cases this season than in any season since the 2009 H1N1 pandemic, and two-thirds of severe cases have occurred in those aged 41 to 64.

Non-influenza vaccine coverage for adults increased somewhat in 2012, but continued to lag behind goals, particularly for racial and ethnic minorities.

Recommendations from health care professionals may improve uptake of the human papillomavirus vaccine, according to a systematic review.

Perceptions of the risk of contracting a sexually transmitted disease after receiving the first dose of the HPV vaccine were not associated with rates of risky sexual activity among adolescent girls, a study finds.

A new study provides evidence that diabetes patients should receive the influenza vaccine, though its results are not as strong as those produced by previous studies.

One in 3 individuals is at risk for developing shingles.